MarketCap
Facebook
X
TelegramQuarterly report 2022-Q3
added 11-03-2022
SeaSpine Holdings Corporation Cash Conversion Cycle 2011-2026 | SPNE
Annual Cash Conversion Cycle SeaSpine Holdings Corporation
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| 299 | 377 | 307 | 270 | 302 | 301 | 294 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 377 | 270 | 307 |
Quarterly Cash Conversion Cycle SeaSpine Holdings Corporation
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | 140 | - | 316 | - | 311 | 300 | 338 | 51.4 | 373 | 467 | 358 | 52 | 308 | 311 | 303 | 48.8 | 267 | 261 | 312 | - | 62.9 | 58.4 | 61.3 | - | 60.3 | 57.7 | 67.3 | - | 70.7 | 69.1 | 67.6 | - | 61.2 | 28.8 | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 467 | 28.8 | 185 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M |  USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
AxoGen
AXGN
|
245 | $ 28.6 | -1.92 % | $ 1.32 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Alphatec Holdings
ATEC
|
240 | $ 12.19 | -3.02 % | $ 1.83 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
111 | - | 1.37 % | $ 20.5 M | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 36.62 | -4.9 % | $ 5.46 K | USA |
 |
Cognyte Software Ltd.
CGNT
|
-4.41 | $ 8.63 | 2.92 % | $ 620 M |  Israel |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 9.51 | -0.94 % | $ 1.29 B | USA |
 |
Electromed
ELMD
|
180 | $ 24.0 | -1.56 % | $ 203 M | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 40.21 | -2.9 % | $ 1.25 B | USA |
 |
EDAP TMS S.A.
EDAP
|
163 | $ 4.21 | -0.94 % | $ 157 M |  France |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
Apyx Medical Corporation
APYX
|
246 | $ 3.16 | -3.07 % | $ 109 M | USA |
 |
Eargo
EAR
|
32.7 | - | - | $ 10.2 M | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B | Israel |
 |
Second Sight Medical Products
EYES
|
-21 | - | -0.97 % | $ 54.4 M | USA |
 |
FONAR Corporation
FONR
|
234 | $ 18.48 | -0.48 % | $ 121 M | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 0.49 | -2.39 % | $ 50.4 M | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Cytosorbents Corporation
CTSO
|
50.6 | $ 0.82 | 1.35 % | $ 44.6 M | USA |
 |
Align Technology
ALGN
|
137 | $ 173.34 | -1.29 % | $ 13 B | USA |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Butterfly Network
BFLY
|
815 | $ 3.65 | -2.93 % | $ 773 M | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Abbott Laboratories
ABT
|
101 | $ 109.92 | -0.95 % | $ 191 B | USA |
 |
IRadimed Corporation
IRMD
|
267 | $ 98.53 | -1.57 % | $ 1.25 B | USA |
 |
Inogen
INGN
|
48.9 | $ 6.46 | -1.37 % | $ 172 M | USA |
 |
InMode Ltd.
INMD
|
234 | $ 13.26 | -1.45 % | $ 857 M | Israel |
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 71.46 | -2.09 % | $ 106 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 18.05 | 1.29 % | $ 423 M | USA |
 |
IRIDEX Corporation
IRIX
|
119 | $ 1.24 | -10.14 % | $ 20 M | USA |
 |
Pulmonx Corporation
LUNG
|
292 | $ 2.03 | 25.78 % | $ 79.4 M | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 2.17 | -3.55 % | $ 1.32 M | USA |
 |
Medtronic PLC
MDT
|
160 | $ 90.96 | -2.2 % | $ 117 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
283 | $ 82.03 | -2.21 % | $ 48 B | USA |